DK1925667T3 - Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser - Google Patents

Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser

Info

Publication number
DK1925667T3
DK1925667T3 DK08002520.8T DK08002520T DK1925667T3 DK 1925667 T3 DK1925667 T3 DK 1925667T3 DK 08002520 T DK08002520 T DK 08002520T DK 1925667 T3 DK1925667 T3 DK 1925667T3
Authority
DK
Denmark
Prior art keywords
cells
sequence
protein
nucleic acid
iia
Prior art date
Application number
DK08002520.8T
Other languages
English (en)
Inventor
Alain Favier
Michel Seve
Original Assignee
Commissariat Energie Atomique
Univ Joseph Fourier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Joseph Fourier filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of DK1925667T3 publication Critical patent/DK1925667T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
DK08002520.8T 2002-11-18 2003-11-18 Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser DK1925667T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0214374A FR2847263B1 (fr) 2002-11-18 2002-11-18 Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
EP03786019A EP1563071B1 (fr) 2002-11-18 2003-11-18 Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications.

Publications (1)

Publication Number Publication Date
DK1925667T3 true DK1925667T3 (da) 2011-04-26

Family

ID=32187667

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03786019T DK1563071T3 (da) 2002-11-18 2003-11-18 Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf
DK08002520.8T DK1925667T3 (da) 2002-11-18 2003-11-18 Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03786019T DK1563071T3 (da) 2002-11-18 2003-11-18 Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf

Country Status (12)

Country Link
US (2) US7851164B2 (da)
EP (3) EP2239272B1 (da)
JP (2) JP4498144B2 (da)
CN (2) CN1738900B (da)
AT (2) ATE494376T1 (da)
AU (1) AU2003295025B2 (da)
CA (1) CA2506331C (da)
DE (2) DE60323664D1 (da)
DK (2) DK1563071T3 (da)
ES (3) ES2361639T3 (da)
FR (1) FR2847263B1 (da)
WO (1) WO2004046355A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus
WO2008083331A2 (en) * 2006-12-29 2008-07-10 The Regents Of The University Of Colorado Diagnostic and therapeutic target for autoimmune diseases and uses thereof
WO2008096009A2 (en) * 2007-02-09 2008-08-14 Mellitech Polymorphism in the slc30a8 gene
WO2009101181A2 (en) * 2008-02-14 2009-08-20 Universite Libre De Bruxelles New plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
WO2010037784A1 (en) * 2008-09-30 2010-04-08 Novo Nordisk A/S G6pc2-encoded beta cell surface tags
US20120070847A1 (en) 2008-11-07 2012-03-22 Jan Jensen Method For Detecting And Purifying Pancreatic Beta Cells
CA2769665A1 (en) * 2009-08-05 2011-02-10 Opko Curna, Llc Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
EP2537859A1 (en) 2011-06-23 2012-12-26 Université de Mons Molecules specifically binding pancreatic beta cells biomarkers
EP2836845B1 (en) 2012-04-13 2018-05-09 DiabetOmics, Inc. Maternal biomarkers for gestational diabetes
CN104098675A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104098673A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
EP3123169B1 (en) * 2014-03-26 2022-05-04 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Flattop (fltp) is a novel biomarker for beta cell maturation
GB201520603D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
US11016085B2 (en) 2016-04-25 2021-05-25 The Johns Hopkins University ZNT8 assays for drug development and pharmaceutical compositions
CN106226526A (zh) * 2016-06-30 2016-12-14 深圳市亚辉龙生物科技股份有限公司 一种锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法
CN111316099A (zh) 2017-07-12 2020-06-19 约翰霍普金斯大学 用于1型糖尿病诊断的基于脂蛋白体的znt8自身抗原
WO2020037174A1 (en) * 2018-08-16 2020-02-20 The Johns Hopkins University Antibodies to human znt8
CN109734793B (zh) * 2019-03-14 2022-12-02 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种ZnT8重组蛋白及其制备方法和应用
US20220340911A1 (en) * 2019-08-13 2022-10-27 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
US12366570B2 (en) 2019-10-01 2025-07-22 The Johns Hopkins University Cell-based ZNT8 assay
AU2022328714A1 (en) 2021-08-20 2024-02-29 The Johns Hopkins University Cell-surface antibody to a specific biomarker of pancreatic beta-cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NL9001083A (nl) 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
US5969210A (en) * 1996-01-22 1999-10-19 Research Development Foundation Methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells
JP2003517592A (ja) * 1999-12-13 2003-05-27 ザ スクリプス リサーチ インスティチュート 膵島αおよびβ前駆体の同定ならびに単離のためのマーカー
WO2001094409A2 (en) * 2000-06-07 2001-12-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
JP2004529607A (ja) * 2000-09-15 2004-09-30 キュラジェン コーポレイション ヒトポリヌクレオチドおよびそれによってコードされるポリペプチド
WO2002060953A2 (en) * 2000-12-15 2002-08-08 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
JP4498144B2 (ja) 2010-07-07
EP2239272A3 (fr) 2010-12-08
EP1563071B1 (fr) 2008-09-17
JP2006506084A (ja) 2006-02-23
EP2239272B1 (fr) 2014-01-01
CN102250242A (zh) 2011-11-23
AU2003295025B2 (en) 2008-09-18
EP1925667A1 (fr) 2008-05-28
JP5202550B2 (ja) 2013-06-05
WO2004046355A2 (fr) 2004-06-03
EP2239272A2 (fr) 2010-10-13
WO2004046355A3 (fr) 2004-09-30
US9568482B2 (en) 2017-02-14
CN1738900A (zh) 2006-02-22
FR2847263A1 (fr) 2004-05-21
ES2314268T3 (es) 2009-03-16
ATE494376T1 (de) 2011-01-15
US20060246442A1 (en) 2006-11-02
CA2506331A1 (fr) 2004-06-03
DE60335676D1 (de) 2011-02-17
ES2454592T3 (es) 2014-04-11
DK1563071T3 (da) 2009-02-02
US7851164B2 (en) 2010-12-14
CN1738900B (zh) 2011-07-06
US20110027807A1 (en) 2011-02-03
DE60323664D1 (de) 2008-10-30
JP2010150262A (ja) 2010-07-08
AU2003295025A1 (en) 2004-06-15
CA2506331C (fr) 2015-02-17
ES2361639T3 (es) 2011-06-20
EP1563071A2 (fr) 2005-08-17
FR2847263B1 (fr) 2006-01-13
EP1925667B1 (fr) 2011-01-05
ATE408689T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
DK1563071T3 (da) Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf
Kind et al. Oxygen‐regulated expression of GLUT‐1, GLUT‐3, and VEGF in the mouse blastocyst
JP2006506084A5 (da)
EP2071025A1 (en) Primer set for amplification of ugt1a1 gene, reagent for amplification of ugt1a1 gene comprising the same, and use of the same
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
CN101568646A (zh) 基因扩增用引物对、含有其的基因扩增用试剂及其用途
DE50111395D1 (de) Screeningverfahren
EP2502994A1 (en) Primer set for amplification of mthfr gene, mthfr gene amplification reagent comprising same, and use of same
CN101619350A (zh) 用于恶性肿瘤个体化用药相关基因突变检测的基因芯片及其应用
US20090208956A1 (en) Primer set for amplifying cyp2c9 gene, reagent for amplifying cyp2c9 gene containing the same, and the uses thereof
KR102124652B1 (ko) 개의 불안장애 조기 예측 또는 진단용 조성물
Sawai et al. Analysis of mRNA transcripts for insulin-like growth factor receptors and binding proteins in bovine embryos derived from somatic cell nuclear transfer
ZA200606354B (en) Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
EP3123169A1 (en) Flattop (fltp) is a novel biomarker for beta cell maturation
PL1706493T3 (pl) Sposób wytwarzania L-treoniny lub L-lizyny obejmujący rekombinowane enterobacteriaceae o ulepszonej aktywności enolazy
US20180127824A1 (en) Diagnosis and Treatment of Genetic Alterations Associated with Eosinophilic Esophagitis
Lepikhov et al. DNA methylation reprograming and DNA repair in the mouse zygote
PT1131424E (pt) Mutações do gene da parkina, composições, métodos e utilizações
CN106434947B (zh) Wnt5a基因作为猪产仔数性状相关检测的分子标记
KR101821552B1 (ko) 돼지의 유두수 예측용 ｓｎｐ 마커 및 이를 이용한 다산 개체 예측방법
Mano et al. IF3, a novel cell-differentiation factor, highly expressed in murine liver and ovary
JPWO2018199136A1 (ja) Ａｂｌ１ ｔ３１５ｉ変異の発現レベルの測定方法
DE602004020603D1 (de) Verfahren zum nachweis des gens einer mutante des pankreatischen insel-amyloidproteins sowie nukleinsäuresonde und kit dafür
KR102194880B1 (ko) 개의 당뇨 위험성 예측용 snp 마커 및 이를 이용한 예측 방법
CN104630362A (zh) 一种精子细胞转录调控相关基因的基因检测方法